Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Patients with colorectal and renal cell carcinoma diagnoses appear to be at risk for additional malignancies.

Steinhagen E, Moore HG, Lee-Kong SA, Shia J, Eaton A, Markowitz AJ, Russo P, Guillem JG.

Clin Colorectal Cancer. 2013 Mar;12(1):23-7. doi: 10.1016/j.clcc.2012.07.004. Epub 2012 Sep 29.

PMID:
23026110
2.

The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.

Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML.

Eur Urol. 2008 Oct;54(4):855-63. doi: 10.1016/j.eururo.2008.04.079. Epub 2008 May 9.

PMID:
18487007
3.

De novo renal cell carcinoma of native kidney in renal transplant recipients.

Neuzillet Y, Lay F, Luccioni A, Daniel L, Berland Y, Coulange C, Lechevallier E.

Cancer. 2005 Jan 15;103(2):251-7.

4.

Does left side renal cell carcinoma (RCC) with renal vein/vena cava thrombus predict worse prognosis than equivalent right side RCC tumor thrombus?

Thiel DD, Lohse CM, Arnold ML, Cheville JC, Leibovich BC, Parker AS.

Int Urol Nephrol. 2012 Aug;44(4):1005-12. doi: 10.1007/s11255-012-0168-2. Epub 2012 Apr 13.

PMID:
22528581
5.

Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature.

Kunthur A, Wiernik PH, Dutcher JP.

Am J Hematol. 2006 Apr;81(4):271-80.

6.

Prospective immunohistochemical analysis of primary colorectal cancers for loss of mismatch repair protein expression.

Lee-Kong SA, Markowitz AJ, Glogowski E, Papadopoulos C, Stadler Z, Weiser MR, Temple LK, Guillem JG.

Clin Colorectal Cancer. 2010 Oct;9(4):255-9. doi: 10.3816/CCC.2010.n.038.

PMID:
20920999
7.

Patient and tumor characteristics may raise clinicians' awareness of familial colorectal cancer: a Norwegian population-based study.

Tranø G, Wasmuth H, Sjursen W, Vatten L.

Scand J Gastroenterol. 2011 Oct;46(10):1236-42. doi: 10.3109/00365521.2011.594086. Epub 2011 Jun 17.

PMID:
21679123
8.

Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.

Mignogna C, Staibano S, Altieri V, De Rosa G, Pannone G, Santoro A, Zamparese R, D'Armiento M, Rocchetti R, Mezza E, Nasti M, Strazzullo V, Montanaro V, Mascolo M, Bufo P.

BMC Cancer. 2006 Dec 19;6:293.

9.

Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.

Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, Belldegrun AS.

Cancer. 2005 Jun 15;103(12):2517-25.

10.

Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?

Soliman PT, Broaddus RR, Schmeler KM, Daniels MS, Gonzalez D, Slomovitz BM, Gershenson DM, Lu KH.

J Clin Oncol. 2005 Dec 20;23(36):9344-50.

PMID:
16361634
11.

Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.

Van Lier MG, De Wilt JH, Wagemakers JJ, Dinjens WN, Damhuis RA, Wagner A, Kuipers EJ, Van Leerdam ME.

Scand J Gastroenterol. 2009;44(5):600-4. doi: 10.1080/00365520802706008.

PMID:
19153873
12.

Diagnosis and treatment of renal cell carcinoma in children: a report from the Polish pediatric rare tumor study group.

Stachowicz-Stencel T, Bien E, Balcerska A, Godzinski J, Synakiewicz A, Perek-Polnik M, Kurylak A, Pietras W, Kuzmicz M, Mizia-Malarz A, Rybczynska A, Nurzynska-Flak J.

Klin Padiatr. 2011 May;223(3):138-41. doi: 10.1055/s-0031-1275349. Epub 2011 Apr 20.

PMID:
21509711
13.

Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.

Shi H, Zhou Y, Liu H, Chen C, Li S, Li N, Li X, Zhang X, Zhang H, Wang W, Zhao Q.

BMC Cancer. 2010 Sep 3;10:477. doi: 10.1186/1471-2407-10-477.

14.

Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS.

Am J Surg Pathol. 1997 Jun;21(6):621-35.

PMID:
9199639
15.

Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.

Losi L, Di Gregorio C, Pedroni M, Ponti G, Roncucci L, Scarselli A, Genuardi M, Baglioni S, Marino M, Rossi G, Benatti P, Maffei S, Menigatti M, Roncari B, Ponz de Leon M.

Am J Gastroenterol. 2005 Oct;100(10):2280-7.

PMID:
16181381
16.

Clinical features and prognosis of patients with renal cancer and a second malignancy.

Antonelli A, Calza S, Arrighi N, Zani D, Corti S, Cozzoli A, Zanotelli T, Cunico SC, Simeone C.

Urol Oncol. 2012 May-Jun;30(3):294-300. doi: 10.1016/j.urolonc.2010.04.013. Epub 2010 Sep 16.

PMID:
20843710
17.

Human immunodeficiency virus--associated renal cell carcinoma: a transatlantic case series.

Gaughan EM, Dezube BJ, Aboulafia D, Bower M, Stebbing J, Powles T, Pantanowitz L.

Clin Genitourin Cancer. 2008 Sep;6(2):86-90. doi: 10.3816/CGC.2008.n.013.

PMID:
18824430
18.

Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.

da Silva NF, Gentle D, Hesson LB, Morton DG, Latif F, Maher ER.

J Med Genet. 2003 Nov;40(11):820-4.

19.
20.

Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.

Schofield L, Goldblatt J, Iacopetta B.

Rural Remote Health. 2011;11(4):1836. Epub 2011 Dec 22.

Supplemental Content

Support Center